期刊
CANCER LETTERS
卷 484, 期 -, 页码 9-15出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2020.04.018
关键词
Hypoxia; Pancreatic ductal adenocarcinoma; Cancer microenvironment; Morphogenesis signaling; Therapeutic target
类别
资金
- Japan Society for the Promotion of Science KAKENHI [JP17H04283 JP18K08620, JP19K09124]
Chemotherapy and immunotherapy for pancreatic ductal adenocarcinoma (PDAC) have limited success. One reason for this is thought to be the cancer microenvironment surrounding PDAC. Hypoxia is a feature of the cancer microenvironment. Under hypoxia, different various molecules and signaling pathways are activated compared with normoxia. To develop a new effective therapeutic strategy for PDAC, we need to target these hypoxic conditions to overcome PDAC. To inhibit the malignant phenotype, the cellular changes that occur under hypoxia should be elucidated. Various molecules and signaling that are activated by hypoxia may contribute to the induction of malignant phenotypes of PDAC such as proliferation, invasion, tumorigenesis, chemosensitivity, and autophagy. If we can develop therapeutic approaches to target one of these molecules or signaling pathways, we may proceed to the next therapeutic step of successfully treating refractory PDAC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据